Evaluating the Efficacy of Tocilizumab in Moderate to Severe COVID-19 with Progressive Illness despite Steroids: Identifying the Optimal Timing of its Administration in C3G study

Surabhi Madan, Manish Rana, Rohan Gajjar, Nitesh Shah, Vipul Thakkar, Bhagyesh Shah, Pradip Dabhi, Minesh Patel, Hardik Shah, Rashmi Chovatiya, Maulik Soni, Nirav Bapat, Amit Patel
doi: https://doi.org/10.1101/2020.11.07.20226837

Data Availability

No URL for external data sets or online supplementary material pertain to this manuscript.

Back to top
Posted November 10, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Evaluating the Efficacy of Tocilizumab in Moderate to Severe COVID-19 with Progressive Illness despite Steroids: Identifying the Optimal Timing of its Administration in C3G study
Surabhi Madan, Manish Rana, Rohan Gajjar, Nitesh Shah, Vipul Thakkar, Bhagyesh Shah, Pradip Dabhi, Minesh Patel, Hardik Shah, Rashmi Chovatiya, Maulik Soni, Nirav Bapat, Amit Patel
medRxiv 2020.11.07.20226837; doi: https://doi.org/10.1101/2020.11.07.20226837
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area